| EffiCacy, Safety and ToLErability of a Novel Ocular ANtiseptic for Ocular Use (CLEAN) (NCT05127525) | iRenix Medical, Inc. | 2021-11-15 |
| Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole (NCT04120636) | Targeted Therapy Technologies, LLC | 2021-03-05 |
| 601 Versus Ranibizumab in Patients With Branch Retinal Vein Occlusion (BRVO) (NCT04667897) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2021-01-28 |
| Assessment Of Peri-papillary Retinal Nerve Fiber Layer Thickness In Patients With Unilateral Branch Retinal Vein Occlusion (NCT06146309) | Al-Azhar University | 2020-12-01 |
| Branch Retinal Vein Occlusion (BRVO) Treatment With Bevacizumab and Dexamethasone or Bevacizumab Only. (NCT04601688) | He Eye Hospital | 2020-10-31 |
| Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole (NCT04120311) | Targeted Therapy Technologies, LLC | 2019-09-01 |
| Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion (NCT03802630) | Novartis Pharmaceuticals | 2019-07-02 |
| Anti-VEGF Instead of Intraoperative Fan-shaped Photocoagulation in BRVO Combined With Vitreous Hemorrhage (NCT03637283) | Wenzhou Medical University | 2018-10-01 |
| Navigated Laser In Branch Retinal Vein Occlusion Study (NCT03651011) | Odense University Hospital | 2018-08-10 |
| Conbercept Ophthalmic Injection for Patients With Macular Edema Caused by Branch Retinal Vein Occlusion (NCT03108352) | Chengdu Kanghong Biotech Co., Ltd. | 2016-04-13 |
| Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVO (NCT02503540) | Justis Ehlers | 2015-08-18 |
| Assessment of Retinal Vessel Diameters and Red Blood Velocities in Patients With BRVO and Healthy Subjects (NCT01746615) | Medical University of Vienna | 2015-08-01 |
| Retinal Sensitivity in BRVO After Anti-VEGF Therapy (NCT02527733) | Fukushima Medical University | 2015-06-01 |
| Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study (NCT02390245) | Wills Eye | 2014-09-01 |
| Evaluation of the Usefulness of a PRN Regimen Using Ranibizumab for Macular Edema Due to Branch Retinal Vein Occlusion (NCT02478515) | Nagoya City University | 2014-01-01 |
| Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein Occlusion (NCT02169648) | Tokyo Medical University | 2013-12-01 |
| Proof of Concept Study of Re-treatment in BRVO With Ranibizumab Guided by OCT (NCT01968239) | University of Leipzig | 2013-10-01 |
| Non-damaging Retinal Laser Therapy With PASCAL Laser for Macular Diseases (NCT01975103) | Federal University of Rio Grande do Sul | 2013-03-01 |
| Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair Vision (NCT01795209) | Seoul National University Bundang Hospital | 2013-01-01 |
| Long-term Treatment Effect of Intravitreal Ant-VEGF in Branch Retinal Vein Occlusion (NCT02033031) | Medical University of Vienna | 2012-08-01 |
| Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein Occlusion (NCT01599650) | Novartis Pharmaceuticals | 2012-05-01 |
| Study to Assess the Clinical Efficacy and Safety of Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) in Patients With Branch Retinal Vein Occlusion (BRVO) (NCT01521559) | Regeneron Pharmaceuticals | 2012-04-01 |
| Retinal Vessel Diameter in Branch Retinal Vein Occlusion (NCT02215109) | Kyungpook National University Hospital | 2012-04-01 |
| Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Living Human Eye (NCT01348633) | University of Toronto | 2012-03-01 |
| Combined Therapy of Posterior Subtenon Triamcinolone Acetonide and Intravitreal Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion (NCT01614509) | Yeungnam University College of Medicine | 2012-01-01 |
| Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab (NCT01471691) | Hanscom, Thomas, M.D. | 2011-11-01 |
| A Research Study to Evaluate the Effects of Repeated Intravitreal Injections on Bacteria Around the Eye (NCT01531842) | Mid Atlantic Retina | 2011-08-01 |
| Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO) (NCT01396057) | Novartis Pharmaceuticals | 2011-07-01 |
| REtinal Vein OccLUsion Treatment With Scatter Laser Guided by UWFA in combiNAtion With Ranibizumab Study (NCT01247220) | Retina Associates of Florida, P.A. | 2010-11-01 |
| Intravitreal Bevasizumab Versus Intravitreal Triamcinolone in Branch Retinal Vein Occlusion (NCT01044329) | Shahid Beheshti University of Medical Sciences | 2010-01-01 |
| Atorvastatin for the Treatment of Retinal Vein Occlusion (NCT00517257) | University of Toronto | 2007-08-01 |
| Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusions (NCT00500045) | Palo Alto Medical Foundation | 2007-02-01 |
| A Pilot Study of Functional Optical Coherence Tomography for Ocular Imaging (NCT00556114) | University of California, Irvine | 2007-01-01 |
| Combined Vitrectomy and Triamcinolone in Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO) (NCT00642226) | Helse Stavanger HF | 2006-11-01 |
| Sheathotomy vs. Intravitreal Triamcinolone for Branch Retinal Vein Occlusion (NCT00612261) | Yonsei University | 2006-10-01 |
| Evaluation of Macugen Treatment of Macular Edema Due to Branch Retinal Vein Occlusion (NCT00406107) | Palmetto Retina Center, LLC | 2006-01-01 |
| Intravitreal Triamcinolone for Acute Branch Retinal Vein Occlusion (NCT00370266) | Shahid Beheshti University of Medical Sciences | 2003-02-01 |
| A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion (NCT00308477) | Sanwa Kagaku Kenkyusho Co., Ltd. | |